BOLD vs GS · P/E 0.1, $24.6M cap vs P/E 20, $324.25B cap
Boundless Bio, Inc. Common Stock (BOLD) versus Goldman Sachs Group Inc (GS) — a side-by-side from cached financials, not a winner call.
Boundless Bio, Inc. Common Stock (BOLD) is a biotechnology company listed on US.
Goldman Sachs Group Inc (GS) is a capital markets company listed on NYSE. It is led by David Solomon.
BOLD does not have a complete income-statement cache yet.
GS does not have a complete income-statement cache yet.
BOLD currently screens at market cap $24.6M and trailing P/E 0.1. GS currently screens at market cap $324.25B and trailing P/E 20.1.
Not investment advice. Open the BOLD and GS stock pages for the full models.
Not investment advice.